Eisen, Howard
(
Thomas Jefferson University
, Philadelphia , Pennsylvania , United States )
Pagidipati, Neha
(
DCRI
, Durham , North Carolina , United States )
Kohut, Andrew
(
Penn Medicine
, Philadelphia , Pennsylvania , United States )
Author Disclosures:
Howard Eisen:DO NOT have relevant financial relationships
| Neha Pagidipati:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Alnylam:Active (exists now)
; Consultant:Esperion:Active (exists now)
; Consultant:Eli Lilly:Active (exists now)
; Consultant:Corsera:Active (exists now)
; Consultant:Corcept:Active (exists now)
; Consultant:Boehringer Ingelheim:Active (exists now)
; Consultant:Bayer:Active (exists now)
; Consultant:Amgen:Active (exists now)
; Research Funding (PI or named investigator):Merck:Active (exists now)
; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now)
; Research Funding (PI or named investigator):Novartis:Active (exists now)
; Research Funding (PI or named investigator):Eli Lilly:Active (exists now)
; Research Funding (PI or named investigator):Boehringer Ingelheim:Active (exists now)
; Research Funding (PI or named investigator):Bayer:Active (exists now)
; Research Funding (PI or named investigator):Amgen:Active (exists now)
| Andrew Kohut:No Answer